3.4-fold higher risk of
stroke and death in CAS compared with CEA.175 In contrast,
a recent study by AbuRahma et al403 of 409 patients who
underwent CAS between 2004 and 2015 found no signiï¬cant difference in stroke and major adverse events in
regards to the stent length, number of stents or stent
diameter after CAS.403 However